Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Top Cited Papers
- 1 September 2009
- journal article
- review article
- Published by Springer Nature in Nature Reviews Drug Discovery
- Vol. 8 (9) , 733-750
- https://doi.org/10.1038/nrd2927
Abstract
Nicotinic receptors - a family of ligand-gated ion channels that mediate the effects of the neurotransmitter acetylcholine - are among the most well understood allosteric membrane proteins from a structural and functional perspective. There is also considerable interest in modulating nicotinic receptors to treat nervous-system disorders such as Alzheimer's disease, schizophrenia, depression, attention deficit hyperactivity disorder and tobacco addiction. This article describes both recent advances in our understanding of the assembly, activity and conformational transitions of nicotinic receptors, as well as developments in the therapeutic application of nicotinic receptor ligands, with the aim of aiding novel drug discovery by bridging the gap between these two rapidly developing fields.Keywords
This publication has 289 references indexed in Scilit:
- TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophreniaBiochemical Pharmacology, 2009
- In Vivo Activation of Midbrain Dopamine Neurons via Sensitized, High-Affinity α6∗ Nicotinic Acetylcholine ReceptorsNeuron, 2008
- Rapsyn carboxyl terminal domains mediate muscle specific kinase–induced phosphorylation of the muscle acetylcholine receptorNeuroscience, 2008
- Crystal structures of Lymnaea stagnalis AChBP in complex with neonicotinoid insecticides imidacloprid and clothianidinInvertebrate Neuroscience, 2008
- α-RgIA, a Novel Conotoxin That Blocks the α9α10 nAChR: Structure and Identification of Key Receptor-Binding ResiduesJournal of Molecular Biology, 2008
- The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatumBiochemical Pharmacology, 2007
- Structure-guided drug design: Conferring selectivity among neuronal nicotinic receptor and acetylcholine-binding protein subtypesBiochemical Pharmacology, 2007
- Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive functionBiochemical Pharmacology, 2007
- Galanthamine and Non-competitive Inhibitor Binding to ACh-binding Protein: Evidence for a Binding Site on Non-α-subunit Interfaces of Heteromeric Neuronal Nicotinic ReceptorsJournal of Molecular Biology, 2007
- Cytisine, a partial agonist of high-affinity nicotinic acetylcholine receptors, has antidepressant-like properties in male C57BL/6J miceNeuropharmacology, 2007